Irie Kazuhiro
,
Kikumori Masayuki
,
Kamachi Hiroaki
,
Tanaka Keisuke
,
Murakami Akira
,
Yanagita Ryo C.
,
Tokuda Harukuni
,
Suzuki Nobutaka
,
Nagai Hiroshi
,
Suenaga Kiyotake
,
Nakagawa Yu
… Bryostatin-1 (bryo-1), a unique PKC activator with little tumor-promoting activity, is currently in clinical trials for the treatment of cancer. … However, its limited availability from natural sources and its synthetic complexity have hampered studies of its mode of action and structural optimization as a therapeutic agent. …
Pure Appl. Chem. 84(6), 1341-1351, 2012-00-00
IR
CrossRef
Cited by (1)